Holen Sie sich die Stockscreener-App
5.34
5.12%
0.26
Vorhandelsmarkt:
5.19
-0.15
-2.81%
Schlusskurs vom Vortag:
$5.08
Offen:
$5.14
24-Stunden-Volumen:
3.04M
Relative Volume:
1.00
Marktkapitalisierung:
$74.99M
Einnahmen:
$37.79M
Nettoeinkommen (Verlust:
$-10.38M
KGV:
-7.3151
EPS:
-0.73
Netto-Cashflow:
$-1.00M
1W Leistung:
+137.33%
1M Leistung:
+133.19%
6M Leistung:
+256.00%
1J Leistung:
+171.07%
1-Tages-Spanne:
$5.10
$6.10
1-Wochen-Bereich:
$2.08
$6.43
52-Wochen-Spanne:
$1.04
$6.43
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Firmenname
Cumberland Pharmaceuticals Inc
Sektor
Telefon
615-255-0068
Adresse
2525 WEST END AVENUE, NASHVILLE,, TN
Vergleichen Sie CPIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
5.34 | 74.99M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
174.12 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.61 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.51 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.29 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
150.51 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2012-11-12 | Bestätigt | UBS | Neutral |
| 2011-02-01 | Bestätigt | UBS | Neutral |
| 2010-12-16 | Herabstufung | UBS | Buy → Neutral |
| 2010-08-17 | Herabstufung | Jefferies | Buy → Hold |
| 2010-08-17 | Bestätigt | Morgan Joseph | Buy |
| 2010-08-17 | Bestätigt | UBS | Buy |
| 2010-05-14 | Bestätigt | Morgan Joseph | Buy |
Alle ansehen
Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten
Financial Survey: Cumberland Pharmaceuticals (NASDAQ:CPIX) versus Skye Bioscience (NASDAQ:SKYE) - Defense World
Adversity is less terrifying than hope: Cumberland Pharmaceuticals Inc (CPIX) - SETE News
Cumberland Pharma (CPIX) Achieves Key Milestone, Stock Jumps - Stocks Telegraph
Cumberland Pharmaceuticals sees nearly 50 million shares trade - Nashville Post
Cumberland Pharmaceuticals reports data from trial of ifetroban for DMD - Yahoo Finance
Cumberland Pharmaceuticals reports data from trial of ifetroban for DMD heart disease - Clinical Trials Arena
Pharma Stock Soars On Phase 2 Announcement - The Globe and Mail
Cumberland Pharmaceuticals stock soars - Nashville Post
Uncovering the Potential of Cumberland Pharmaceuticals Inc (CPIX) Stock - The InvestChronicle
Cumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease - Benzinga
Stock market news: Nuvve Holding +47.92%, Flexsteel Industries +28.15% among top gainers during mid day trading - Business Upturn
Cumberland Pharmaceuticals Inc (CPIX) Stock Price and Analyst Predictions - The News Heater
Is CPIX’s price to cash per share ratio a concern for investors? - US Post News
Cumberland reports progress in DMD heart disease trial - MSN
Cumberland's Duchenne drug improves blood flow from heart in phase 2 trial - Fierce Biotech
Cumberland Vaults on DMD Test Results - Baystreet.ca
Cumberland Pharmaceuticals Announces Phase 2 Fight Dmd Trial Results For Duchenne Muscular Dystrophy Heart Disease - Marketscreener.com
Cumberland's DMD Heart Disease Drug Shows Breakthrough 5.4% LVEF Improvement in Phase 2 | CPIX Stock News - StockTitan
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Hepatorenal Syndrome Treatment Market: Increasing Demand, Market Size, and Foreseen Trends for 2024-2029 - openPR
Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs - openPR
StockNews.com Initiates Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX) - Defense World
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
SAP (SAP) Expected to Announce Earnings on Tuesday - Defense World
Advancements in Ocular Hypertension Clinical Trial Pipeline - GlobeNewswire
3 US Penny Stocks With Market Caps Over $30M - Yahoo Finance
Dilated Cardiomyopathy Pipeline Overview 2024: FDA Approvals and Key Developments | Vericel Corporation, AstraZeneca, Pfizer, Zensun Shanghai Sci & Tech Co Ltd, Capricor Therapeutics - The Globe and Mail
Improved Revenues Required Before Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Stock's 26% Jump Looks Justified - Simply Wall St
Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.
CPIX stock touches 52-week high at $3.09 amid market rally - Investing.com
scPharmaceuticals Provides Preliminary Financial Results for Fourth Quarter and Full Year 2024On January 10, 2025, scPharmaceuticals Inc. (NASDAQ: SCPH) released an 8-K filing containing preliminary unaudited financial information for the quarter and - Defense World
Cumberland Pharmaceuticals (NASDAQ:CPIX) Coverage Initiated at StockNews.com - Defense World
Cumberland Pharmaceuticals director Krogulski buys $8,209 in stock - Investing.com India
Cumberland Pharmaceuticals director James Jones acquires $1,317 in stock By Investing.com - Investing.com Nigeria
Cumberland Pharmaceuticals CEO AJ Kazimi purchases $1317 in stock By Investing.com - Investing.com Nigeria
Cumberland Pharmaceuticals director Krogulski buys $8,209 in stock By Investing.com - Investing.com Canada
Cumberland Pharmaceuticals director Caroline Young acquires $256 in stock By Investing.com - Investing.com Canada
Cumberland Pharmaceuticals director James Jones acquires $1,317 in stock - Investing.com India
Cumberland Pharmaceuticals CEO AJ Kazimi purchases $1317 in stock - Investing.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by StockNews.com - Defense World
Athira Pharma (NASDAQ:ATHA) Stock Quotes, Forecast and News Summary - Benzinga
StockNews.com Begins Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX) - Defense World
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
3 Penny Stocks to Watch Now, 12/12/24 - TipRanks
3 Promising Penny Stocks With Market Caps Under $2B In US - Simply Wall St
FDA APPROVES ACETADOTE® sNDA - Citizentribune
Cumberland Pharmaceuticals stock pops - Nashville Post
Cumberland Stock Soars 90% After FDA Approval for Acetadote Dosing Change - GuruFocus.com
Stock Skyrockets! Discover What’s Fueling This Company’s Massive Surge. - elblog.pl
Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings - Benzinga
Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):